ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,540Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 3734

$884K Total Retail Price of All Prescriptions

Rank: 164 out of 3734

455 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 455 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 12,864 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 660 501 1 1
LEVOTHYROXINE SODIUM 634 524 2 2
AMLODIPINE BESYLATE 471 437 3 5
OMEPRAZOLE 458 381 4 4
WARFARIN SODIUM 450 425 5 10
LISINOPRIL 438 353 6 3
FUROSEMIDE 356 318 7 7
METOPROLOL TARTRATE 310 264 8 6
MIRTAZAPINE 292 273 9 45
DONEPEZIL HCL 284 279 10 25
POTASSIUM CHLORIDE 256 222 11 19
PRAVASTATIN SODIUM 225 222 12 15
METFORMIN HCL 200 169 13 8
BYSTOLIC 190 178 14 148
NIASPAN 188 139 15 125
AMLODIPINE BESYLATE-BENAZEPRIL 186 184 16 56
ATORVASTATIN CALCIUM 181 148 17 11
BUMETANIDE 175 146 18 78
NAMENDA 174 168 19 44
CITALOPRAM HBR 161 101 20 16
ISOSORBIDE MONONITRATE ER 154 152 21 34
SERTRALINE HCL 154 141 21 18
FLUOXETINE HCL 154 71 21 61
RANITIDINE HCL 153 113 24 32
MELOXICAM 140 132 25 52
RISPERIDONE 139 136 26 62
METOPROLOL SUCCINATE 139 131 26 14
CLOPIDOGREL 136 119 28 23
HYDROCODONE-ACETAMINOPHEN 133 71 S3 29 12
PREDNISONE 132 116 30 42
CRESTOR 128 89 31 28
KLOR-CON M20 127 114 32 48
ATENOLOL 120 100 33 13
PLAVIX 116 93 34 39
TAMSULOSIN HCL 108 108 35 29
PANTOPRAZOLE SODIUM 107 77 36 22
GABAPENTIN 106 57 37 17
SPIRIVA 104 92 38 40
OXYCODONE-ACETAMINOPHEN 103 74 S2 39 51
ZETIA 103 98 39 55
DIGOXIN 101 101 41 43
ALLOPURINOL 92 92 42 33
GLIMEPIRIDE 91 77 43 37
CARVEDILOL 89 77 44 30
BENICAR 83 83 45 107
DIOVAN 82 58 46 31
NYSTATIN 81 29 47 162
SYMBICORT 80 70 48 186
ADVAIR DISKUS 80 59 48 35
OXYCONTIN 76 20 S2 50 121
HYDROCHLOROTHIAZIDE 76 75 50 9
ZOLPIDEM TARTRATE 75 45 52 24
VYTORIN 71 49 53 163
CIPROFLOXACIN HCL 68 66 54 77
NEXIUM 67 67 55 36
TRAMADOL HCL 67 57 55 20
ALBUTEROL SULFATE 67 66 55 128
CEFUROXIME 64 58 58 168
FLUTICASONE PROPIONATE 64 45 58 46
METFORMIN HCL ER 64 53 58 66
ALENDRONATE SODIUM 63 51 61 26
LANTUS 63 42 61 54
GLYBURIDE-METFORMIN HCL 63 49 R 61 154
OXYCODONE HCL-ACETAMINOPHEN 62 0 S2 64 122
AGGRENOX 61 55 65 182
FENTANYL 61 48 S2 65 65
PAROXETINE HCL 59 56 67 59
TRILIPIX 58 47 68 195
NOVOLOG 58 57 68 112
CLOTRIMAZOLE-BETAMETHASONE 56 47 70 135
JANUVIA 56 56 70 50
KLOR-CON 10 56 45 70 140
TRAZODONE HCL 55 31 73 49
TORSEMIDE 52 52 74 160
CLONIDINE HCL 52 50 74 79
LIPITOR 51 44 76 90
INSULIN SYRINGE 51 34 76 109
CYMBALTA 50 25 78 67
DIVALPROEX SODIUM 50 45 78 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.